Implantable Cardiac Devices Market Expected to Achieve 8.8% CAGR by 2029: Growth Forecast Insights

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Implantable Cardiac Devices Market Size By 2025?
The market size for implantable cardiac devices has seen a robust growth in the past few years. The market size is projected to increase from $12.34 billion in 2024 to $13.34 billion in 2025, representing a compound annual growth rate (CAGR) of 8.1%. The factors contributing to this increase in the previous time frame include advancements in medical technology, a rise in cardiovascular diseases, an aging population boom, enhancements in gadget durability and reliability, increased awareness, and prompt diagnosis of heart conditions.

How Big Is the Implantable Cardiac Devices Market Size Expected to Grow by 2029?
The market for implantable cardiac devices is anticipated to experience substantial growth in the coming years, reaching $18.69 billion in 2029 with a CAGR of 8.8%. This projected growth can be attributed to several factors such as advancements in device functionality, growing demand for minimally invasive procedures, a swelling aging population, increased healthcare spending, and the development of healthcare infrastructure in emerging markets. Key trends during this forecast period include the incorporation of digital health and remote patient monitoring, creation of upgraded next-gen devices with improved capabilities, rising trends in personalized cardiac solutions, a focus on cost efficiency and value-oriented healthcare, along with a growing attention towards preventive cardiology and early interventions.

View the full report here:
https://www.thebusinessresearchcompany.com/report/implantable-cardiac-devices-global-market-report

Which Key Market Drivers Powering Implantable Cardiac Devices Market Expansion and Growth?
The escalating prevalence of heart diseases is set to drive the expansion of the implantable cardiac devices market. The increase in heart ailments is linked to the rising incidence of risk factors like unhealthy diet choices, lack of physical activity, obesity, and chronic diseases such as diabetes and hypertension. The aging demographic and heightened stress levels also add to the increased occurrence of cardiovascular ailments. Implantable cardiac devices are employed to manage and treat ailments like heart failure, arrhythmias and coronary artery disease. This surging requirement drives innovation and financial backing in the creation of novel and advanced cardiac devices, designed to cater to the swelling patient populace and improve treatment results. For example, the Singapore Heart Foundation (SHF) reported in May 2024 that ischemic heart disease caused 5,302 deaths, a marginal climb from 5,290 deaths in 2022. Consequentially, the escalating prevalence of heart disease propels the expansion of the implantable cardiac devices market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19097&type=smp

Which Emerging Trends Are Transforming the Implantable Cardiac Devices Market in 2025?
Leading entities in the implantable cardiac devices market are emphasizing on boosting their compatibility with diagnostic equipment like AutoMRI. This will not only prolong the lifespan of the device but will also elevate patient safety. AutoMRI feature in implantable cardiac defibrillators customizes the settings of the device to guarantee its safe utilization during MRI scans. This enhances patient care and provides access to the latest imaging technology. For example, MicroPort CRM, a medical device firm based in France, in October 2023, introduced the ULYS implantable cardioverter defibrillator (ICD) and INVICTA defibrillation leads in Japan. These products are renowned for their cutting-edge technology, low power usage, extended device longevity, and MRI compatibility. The ULYS ICD is equipped with the advanced PARAD+ arrhythmia discrimination algorithm and AutoMRI features, while INVICTA lead offers precise pacing and defibrillation treatment, showing 100% implantation success rate and 97.4% complication-free rate in clinical tests.

What Are the Emerging Segments in the Implantable Cardiac Devices Market?
The implantable cardiac devices market covered in this report is segmented -

1) By Type: Pacemaker, Implantable Cardioverter Defibrillator (ICD), Biventricular Implantable Cardioverter Defibrillator (BI-V ICD)
2) By Application: Bradycardia, Tachycardia, Heart Failure, Other Applications
3) By End User: Hospitals, Specialty Clinics, Other End Users

Subsegments:
1) By Pacemaker: Single-Chamber Pacemakers, Dual-Chamber Pacemakers, Rate-Responsive Pacemakers
2) By Implantable Cardioverter Defibrillator (ICD): Transvenous ICDs, Subcutaneous ICDs, Wearable Cardioverter Defibrillators
3) By Biventricular Implantable Cardioverter Defibrillator (BI-V ICD): Standard BI-V ICDs, Advanced BI-V ICDs with Cardiac Resynchronization Therapy (CRT)

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=19097&type=smp

Who Are the Global Leaders in the Implantable Cardiac Devices Market?
Major companies operating in the implantable cardiac devices market are Johnson & Johnson, Abbott Laboratories, Medtronic plc, Koninklijke Philips N.V., Stryker Corporation, Boston Scientific Corporation, B. Braun Melsungen AG, Edwards Lifesciences Corporation, Biotronik SE & Co. KG, Zoll Medical Corporation, Nihon Kohden Corporation, LivaNova plc, Lepu Medical Technology, MicroPort Scientific Corporation, AtriCure Inc., LifeTech Scientific Corporation, Berlin Heart GmbH, EBR Systems Inc., Defibtech LLC, CVRx Inc., Progetti Srl, Endotronix Inc., Jarvik Heart Inc., Xeltis AG, Carmat SA, Windmill Cardiovascular Systems Inc

Which are the Top Profitable Regional Markets for the Implantable Cardiac Devices Industry?
North America was the largest region in the implantable cardiac devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the implantable cardiac devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19097

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.